Jefferies Group assumed coverage on shares of China Biologic Products (NASDAQ:CBPO) in a report released on Thursday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $52.00 price objective on the stock. China Biologic Products Inc (NASDAQ:CBPO) stock performance was 1.37% in last session and finished the day at $43.67. Traded volume was 59,338.00million shares in the last session and the average volume of … Continue reading New Highs: China Biologic Products Inc (NASDAQ:CBPO), Centene Corp (NYSE:CNC), LifePoint Hospitals, Inc. (NASDAQ:LPNT), Universal Health Services, Inc. (NYSE:UHS)